上海交通大学学报（医学版）

上海交通大学学报（医学版）

• 论著（公共卫生） • 上一篇    下一篇

门诊糖尿病患者降糖类药物利用情况分析

陈彬1,2，吴斌1,2，程华丰1,2   

  1. 上海交通大学 医学院 1.附属仁济医院南院药剂科， 上海 201112； 2.附属仁济医院药剂科, 上海 200127
  • 出版日期:2015-12-28 发布日期:2016-01-21
  • 通讯作者: 程华丰, 电子信箱: findyoush@qq.com。
  • 作者简介:陈彬（1978—）， 男， 药师， 学士; 电子信箱: chenbin@renji.com。
  • 基金资助:

    国家自然科学基金（71373160）

Analysis of use of glucose lowering drugs for outpatients with diabetes

CHEN Bin1,2, WU Bin1,2, CHENG Hua-feng1,2   

  1. 1.Department of Pharmacy， Renji Hospital South Campus, Shanghai Jiao Tong University School of Medicine, Shanghai 201112, China； 2.Department of Pharmacy， Renji Hospital， Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
  • Online:2015-12-28 Published:2016-01-21
  • Supported by:

    National Natural Science Foundation of China，71373160

PDF (PC)

985

摘要：

目的  评价上海交通大学医学院附属仁济医院南院（简称“仁济南院”）降糖药物的用药合理性。方法  采用药物利用评估方法，收集2013年第1季度—2015年第2季度仁济南院非胰岛素依赖型糖尿病患者的用药信息并进行统计学分析。结果  抗糖尿病药物处方量逐年上升，2015年第2季度销售金额是2013年第1季度的近3倍，胰岛素类药物的占比近50%，其中普通胰岛素注射液（国产）无论销售金额还是用药频度（DDDs）均排名第一。DDDs显示常用的口服降糖药是格列齐特缓释片（进口）、二甲双胍（进口）与伏格列波糖（进口）。销售金额排序与DDDs排序比值大于1与小于1的各有6个（24%）与16个（64%）。结论  随着糖尿病患者门诊人数的增加，仁济南院的降糖药物处方量与销售金额显著上升。虽然降糖药物的使用基本合理，但应该更多地选择用药金额与DDDs同步性好的药物。

关键词: 降糖药物, 药物利用评估, 合理用药

Abstract:

Objective  To evaluate the rationality of the use of glucose lowering drugs for the Renji Hospital South Campus, Shanghai Jiao Tong University School of Medicine. Methods  The drug use and evaluation method was adopted and drug use information of patients with type 2 diabetes who were admitted by the Renji Hospital South Campus from the first quarter of 2013 to the second quarter of 2015 was collected and statistically analyzed. Results  The prescriptions of glucose lowering drugs increased annually. The sales amount of the second quarter of 2015 was about 3 times higher than that of the first quarter of 2013. Insulin drugs accounted for about 50% and both the sales amount and defined daily dose (DDD) of general insulin injection (domestic) were ranked as No.1 among all drugs. According to DDDs, commonly used oral glucose lowering drugs were gliclazide (imported), metformin (imported), and voglibose (imported). There were 6 drugs (24%) and 16 drugs (64%) with the ratio of ranks of sales amount and DDD larger than 1 and smaller than 1. Conclusion  The prescriptions and sales amount of glucose lowering drugs of Renji Hospital South Campus increase significantly with the number of outpatients with type 2 diabetes. Basically, the use of the glucose lowering drugs is reasonable, but drugs with better synchronization of the cost and the frequency should be used.

Key words: glucose lowering drugs, drug use evaluation, rational drug use